SYMPHONY MEDICAL INC has a total of 14 patent applications. Its first patent ever was published in 2004. It filed its patents most often in EPO (European Patent Office), Canada and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets medical technology and pharmaceuticals are GREENER BRYAN, SWISS VX VENENTHERAPIE UND FORSCHUNG GMBH and NEW X NAT TECHNOLOGY K K.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 5 | |
#2 | Canada | 4 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | Australia | 1 | |
#5 | China | 1 |
# | Industry | |
---|---|---|
#1 | Medical technology | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Syringes | |
#4 | Object sterilising | |
#5 | Implantable devices | |
#6 | Electrotherapy |
# | Name | Total Patents |
---|---|---|
#1 | Lee Randall J | 8 |
#2 | Hinson Andrew G | 7 |
#3 | Sabbah Hani N | 7 |
#4 | Maciejewski Mark | 5 |
#5 | Peters Nicholas S | 3 |
#6 | Mazgalev Todor N | 3 |
#7 | Youhua Zhang | 1 |
#8 | Rauh Francis | 1 |
#9 | Mark Maciejewski | 1 |
#10 | Ahmann Frank A | 1 |
Publication | Filing date | Title |
---|---|---|
EP2051661A1 | Intramyocardial patterning for global cardiac resizing and reshaping | |
WO2007123851A2 | Method and apparatus for modifying electrical conduction in the heart with profibrotic blood progenitor cells | |
CN1878521A | Control of cardiac arrhythmias by modification of neuronal conduction within fat pads of the heart |